ES2113333T1 - Peptidos que reaccionan con anticuerpos que representan el marcador de pronostico de la progresion de la enfermedad del sida. - Google Patents
Peptidos que reaccionan con anticuerpos que representan el marcador de pronostico de la progresion de la enfermedad del sida.Info
- Publication number
- ES2113333T1 ES2113333T1 ES97107975T ES97107975T ES2113333T1 ES 2113333 T1 ES2113333 T1 ES 2113333T1 ES 97107975 T ES97107975 T ES 97107975T ES 97107975 T ES97107975 T ES 97107975T ES 2113333 T1 ES2113333 T1 ES 2113333T1
- Authority
- ES
- Spain
- Prior art keywords
- peptides
- progression
- react
- aids
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 208000030507 AIDS Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000003550 marker Substances 0.000 title 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 2
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 208000029462 Immunodeficiency disease Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007813 immunodeficiency Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
ESTA INVENCION SE REFIERE A LAS SECUENCIAS DE PEPTIDOS QUE REACCIONAN CON ANTICUERPOS HUMANOS CUYO TITULO EN EL SUERO DE INDIVIDUOS INFECTADOS CON EL VIRUS DE LA INMUNODEFICIENCIA HUMANA DE TIPO I (VIH-1) SE CORRELACIONA CON LA PROGRESION DEL SINDROME DE INMUNODEFICIENCIA ADQUIRIDA (SIDA). POR LO TANTO, ESTOS PEPTIDOS SON UTILES EN LA PREPARACION DE KITS DE ANALISIS PARA EVALUAR EL PRONOSTICO DE LA PROGRESION DE LA ENFERMEDAD, ASI COMO PARA MONITORIZAR EL EFECTO DE LA TERAPIA ANTIVIRAL SOBRE LA INFECTIVIDAD DEL VIH-1 Y PARA MODULAR LA RESPUESTA INMUNE. ESTOS PEPTIDOS TAMBIEN SON UTILES EN VACUNAS PARA PREVENIR EL DESARROLLO DEL SIDA. LOS ANTICUERPOS MONOCLONALES FRENTE A LOS PEPTIDOS DE ESTA INVENCION TAMBIEN PUEDEN UTILIZARSE COMO AGENTES TERAPEUTICOS PARA PREVENIR LA PROGRESION DEL SIDA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9610673A GB2313376A (en) | 1996-05-22 | 1996-05-22 | Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP) |
GB9623340A GB2319252A (en) | 1996-11-08 | 1996-11-08 | Polypeptides involved in the interaction of HIV gp120 with the fusin, and the CC-CKR-5 co-receptors thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2113333T1 true ES2113333T1 (es) | 1998-05-01 |
Family
ID=26309377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97107975T Pending ES2113333T1 (es) | 1996-05-22 | 1997-05-16 | Peptidos que reaccionan con anticuerpos que representan el marcador de pronostico de la progresion de la enfermedad del sida. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20010007017A1 (es) |
EP (1) | EP0808846A3 (es) |
JP (1) | JPH10237100A (es) |
CA (1) | CA2205077A1 (es) |
DE (1) | DE808846T1 (es) |
ES (1) | ES2113333T1 (es) |
GR (1) | GR980300031T1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103412490B (zh) * | 2013-08-14 | 2015-09-16 | 山东大学 | 用于多机器人动态路径规划的多克隆人工免疫网络算法 |
US20220205030A1 (en) * | 2019-02-11 | 2022-06-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Vaccine-induced gene signatures correlating with protection against hiv and siv infection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989005821A1 (en) * | 1987-12-21 | 1989-06-29 | Arch Development Corporation | Hiv-related antigens and antibodies |
FR2677364A1 (fr) * | 1991-06-05 | 1992-12-11 | Pasteur Institut | Sequences peptidiques de la glycoproteine externe d'enveloppe du retrovirus hiv-1. |
FR2687404B1 (fr) * | 1992-02-19 | 1994-05-20 | Centre Nal Recherc Scientifique | Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques. |
-
1997
- 1997-05-16 DE DE0808846T patent/DE808846T1/de active Pending
- 1997-05-16 EP EP97107975A patent/EP0808846A3/en not_active Withdrawn
- 1997-05-16 ES ES97107975T patent/ES2113333T1/es active Pending
- 1997-05-21 US US08/859,699 patent/US20010007017A1/en not_active Abandoned
- 1997-05-21 JP JP9130879A patent/JPH10237100A/ja active Pending
- 1997-05-21 CA CA002205077A patent/CA2205077A1/en not_active Abandoned
-
1998
- 1998-05-29 GR GR980300031T patent/GR980300031T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0808846A2 (en) | 1997-11-26 |
DE808846T1 (de) | 1998-06-25 |
CA2205077A1 (en) | 1997-11-22 |
EP0808846A3 (en) | 1998-08-26 |
US20010007017A1 (en) | 2001-07-05 |
JPH10237100A (ja) | 1998-09-08 |
GR980300031T1 (en) | 1998-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR16C0028I2 (fr) | Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques | |
ES2126620T3 (es) | Retrovirus del grupo de los vih y su utilizacion. | |
ES2100174T3 (es) | Nuevos anticuerpos reactivos con carcinomas humanos. | |
DK0980387T3 (da) | PRRSV-antigene sites, der identificerer peptidsekvenser af PRRS-virus, til anvendelse i vacciner eller diagnostiske assays | |
ES2054696T3 (es) | Agente viral de la hepatitis nanb, antigen y reactivo inmunologico. | |
ES2180754T3 (es) | Compuestos y metodos para la deteccion de infeccion por t. cruzi. | |
MX9304837A (es) | Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico. | |
ES2133772T3 (es) | Inmunoensayo para la homocisteina. | |
ES2065863T3 (es) | Analisis para la deteccion de virus de la hepatitis c. | |
CY1111567T1 (el) | Ενδιαμεσα διβενζο (b,f) αζεπινης | |
ES2097748T3 (es) | Uso de derivados funcionales de la molecula de adhesion intercelular icam-1 en la terapia antivirica. | |
CY1108020T1 (el) | Μονοκλωνικα αντισωματα στον ανθρωπινο υποδοχεα ldl, η παραγωγη και χρηση τους | |
ES2074062T3 (es) | Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda. | |
CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
ES2115584T3 (es) | Antigeno sintetico para la deteccion de enfermedades referentes al sida. | |
UY26370A1 (es) | "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación". | |
ES2115622T3 (es) | Clones moleculares de hiv-1 y usos de los mismos. | |
DE69033745D1 (de) | Oberflächenaktive zusammensetzungen und verfahren | |
MX9301675A (es) | Composiciones que contienen peptidos para inducir tolerancia de las celulas t a un antigeno. | |
GT199900214A (es) | Combinacion de cerivastatina y fibratos. | |
EE05474B1 (et) | Antikehade kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nhtud vhivastaseks vaktsineerimiseks | |
DK1021534T3 (da) | Hepatitis C-receptorprotein CD81 | |
ES2113333T1 (es) | Peptidos que reaccionan con anticuerpos que representan el marcador de pronostico de la progresion de la enfermedad del sida. | |
AR003941A1 (es) | Anticuerpos monoclonales humanos neutralizadores de hiv-1 | |
ES2168253T3 (es) | Peptidos especificos para hcmv y su utilizacion. |